Drug Shortage Report for VINBLASTINE SULPHATE INJECTION

Last updated on 2019-10-10 History
Report ID 92198
Drug Identification Number 02401460
Brand name VINBLASTINE SULPHATE INJECTION
Common or Proper name VINBLASTINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VINBLASTINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-22
Estimated end date 2019-10-31
Actual end date 2019-10-09
Shortage status Resolved
Updated date 2019-10-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-10-10 French Compare
v8 2019-10-10 English Compare
v7 2019-09-26 French Compare
v6 2019-09-26 English Compare
v5 2019-09-19 French Compare
v4 2019-09-19 English Compare
v3 2019-08-23 English Compare
v2 2019-08-22 French Compare
v1 2019-08-22 English Compare